How Do Defective Drugs Reach the Market? Miami Pharmaceutical Attorney Explains

Pharmaceutical litigation is one of my favorite
parts of my practice. The saddest thing about the pharmaceutical litigation cases is people
are taking drugs for a reason. Usually because they’re sick or they have some kind of medical
illness and in fact the drug that’s supposed to help them ends up hurting them. The drugs
are either improperly manufactured; they have missing ingredients or there may be a lack
of quality control in the plant where the drugs are being manufactured. Or they simply
may have the wrong blend. There’s a myth out there that because the product is FDA-tested
or FDA-approved that the drug is safe. We’ve learned that that is not the case. Oftentimes
it takes several years of testing and the companies are aggressively putting their products
on the market in order to sell sell sell, and when they sell sell sell, they sacrifice
safety. Many times there are studies that are at these companies that find that these
drugs are in fact defective, yet they still put them on the market. It’s these skills
in investigating these claims, in investigating the companies, in investigating their actions,
investigating their actions with the government that has led us to successful results in these
cases. For more information, you can contact Colson
Hicks Eidson at our website, Colson.com.

Leave a Reply

(*) Required, Your email will not be published